Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

• Status: Enrolling by invitation
• Trial end date: 2023-11-01
• Target enrollment: 0
• Participant gender: All

Summary

Bell's palsy, a peripheral facial nerve paresis, is the most common disorder of the facial nerve and one of the most common mononeuropathies.

Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: October 6 University
• Treatments: Cerebrolysin; Prednisolone

Criteria

Inclusion Criteria:

• unilateral acute facial palsy of no identifiable cause

Exclusion Criteria:

• Recurrent facial Bell's palsy

• Pregnancy

• Diabetes

• Epilepsy

• Severe hypertension,

• Renal or hepatic disease,

• Gastric or duodenal ulcer

• presence of acute otitis media or ipsilateral chronic otitis

• Recent head injury,

• psychiatric disease

• If there is any contraindications for corticosteroids